Laryssa Huryn

Dr. Laryssa Huryn

Ophthalmic Genetics and Visual Function Branch, National Institutes of Health, 10 Center Drive Rm 10D45, Bethesda, MD 20892, USA

Research Focus & Metrics

Academic Career Length

8Years (2019-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
17 February 2021 in Biomedical Optics Express
Verified
Journal Article
Open access
PDF file
ABAndrew Bower
Andrew Bower
TLTao Liu
Tao Liu
NANancy Aguilera
Nancy Aguilera
JLJoanne Li
Joanne Li
JLJianfei Liu
Jianfei Liu
JTJohnny Tam
Johnny Tam
In vivo imaging of human retinal pigment epithelial (RPE) cells has been demonstrated through multiple adaptive optics (AO)-based modalities. However, whether consistent and complete information regarding the cellular structure of the RPE mosaic is obtained across these modalities remains uncertain due to limited comparisons performed in the same eye. Here, an imaging platform combining multimodal AO-scanning light ophthalmoscopy (AO-SLO) with AO-optical coherence tomography (AO-OCT) is developed to make a side-by-side comparison of the same RPE cells imaged across four modalities: AO-darkfield, AO-enhanced indocyanine green (AO-ICG), AO-infrared autofluorescence (AO-IRAF), and AO-OCT. Co-registered images were acquired in five subjects, including one patient with choroideremia. Multimodal imaging provided multiple perspectives of the RPE mosaic that were used to explore variations in RPE cell contrast in a subject-, location-, and even cell-dependent manner. Estimated cell-to-cell spacing and density were found to be consistent both across modalities and with normative data. Multimodal images from a patient with choroideremia illustrate the benefit of using multiple modalities to infer the cellular structure of the RPE mosaic in an affected eye, in which disruptions to the RPE mosaic may locally alter the signal strength, visibility of individual RPE cells, or even source of contrast in unpredictable ways.

2 November 2022 in Ophthalmology
Verified
Journal Article
Open access
LHLaryssa Huryn
Laryssa Huryn
CKChristina Torres Kozycki
Christina Torres Kozycki
JSJasmine Y. Serpen
Jasmine Y. Serpen
WZWadih Zein
Wadih Zein
EUEhsan Ullah
Ehsan Ullah
SKShilpa Kodati
Shilpa Kodati
We aimed to characterize the ocular phenotype of patients with ROSAH (retinal dystrophy, optic nerve edema, splenomegaly, anhidrosis, and headache) syndrome and their response to therapy. Single-center observational case study. Eleven patients with a diagnosis of ROSAH syndrome and mutation in ALPK1 were included. Patients with molecularly confirmed ROSAH syndrome underwent ophthalmic evaluation, including visual acuity testing, slit-lamp and dilated examinations, color fundus and autofluorescence imaging, fluorescein angiography, OCT, and electrophysiologic testing. Visual acuity, electrophysiology, fluorescein angiography, and OCT findings. Eleven individuals (6 female and 5 male patients) from 7 families ranging in age from 7.3 to 60.2 years at the time of the initial evaluation were included in this study. Seven patients were followed up for a mean of 2.6 years (range, 0.33–5.0 years). Best-corrected visual acuity at baseline ranged from 20/16 to no light perception. Variable signs or sequelae of intraocular inflammation were observed in 9 patients, including keratic precipitates, band keratopathy, trace to 2+ anterior chamber cells, cystoid macular edema, and retinal vasculitis on fluorescein angiography. Ten patients were observed to show optic disc elevation and demonstrated peripapillary thickening on OCT. Seven patients showed retinal degeneration consistent with a cone–rod dystrophy, with atrophy tending to involve the posterior pole and extending peripherally. One patient with normal electroretinography findings and visual evoked potential was found to have decreased Arden ratio on electrooculography. Leveraging insights from the largest single-center ROSAH cohort described to date, this study identified 3 main factors as contributing to changes in visual function of patients with ROSAH syndrome: optic nerve involvement; intraocular inflammation, including cystoid macular edema; and retinal degeneration. More work is needed to determine how to arrest the progressive vision loss associated with ROSAH syndrome. Proprietary or commercial disclosure may be found after the references.

1 February 2019 in Ophthalmology
Verified
Journal Article
Closed access
LHLaryssa Huryn
Laryssa Huryn
ATAmy Turriff
Amy Turriff
LHLaura A. Harney
Laura A. Harney
ACAnn Garrity Carr
Ann Garrity Carr
PCPatricia Chevez-Barrios
Patricia Chevez-Barrios
DSDouglas R. Stewart
Douglas R. Stewart

25 January 2022 in JCI Insight
Verified
Journal Article
Open access
PDF file
MPMaximilian Pfau
Maximilian Pfau
CCCatherine A. Cukras
Catherine A. Cukras
LHLaryssa Huryn
Laryssa Huryn
WZWadih Zein
Wadih Zein
EUEhsan Ullah
Ehsan Ullah
BBBrian P. Brooks
Brian P. Brooks
BACKGROUND: Outcome measures sensitive to disease progression are needed for ATP-binding cassette, sub-family A, member 4–associated ( ABCA4 -associated) retinopathy. We aimed to quantify ellipsoid zone (EZ) loss and photoreceptor degeneration beyond EZ-loss in ABCA4 -associated retinopathy and investigate associations between photoreceptor degeneration, genotype, and age. METHODS: We analyzed 132 eyes from 66 patients (of 67 enrolled) with molecularly confirmed ABCA4 -associated retinopathy from a prospective natural history study with a median [IQR] follow-up of 4.2 years [3.1, 5.1]. Longitudinal spectral-domain optical coherence tomography volume scans (37 B-scans, 30° × 15°) were segmented using a deep learning (DL) approach. For genotype-phenotype analysis, a model of ABCA4 variants was applied with the age of criterion EZ-loss (6.25 mm 2 ) as the dependent variable. RESULTS: Patients exhibited an average (square-root-transformed) EZ-loss progression rate of [95% CI] 0.09 mm/y [0.06, 0.11]. Outer nuclear layer (ONL) thinning extended beyond the area of EZ-loss . The average distance from the EZ-loss boundary to normalization of ONL thickness (to ±2 z score units) was 3.20° [2.53, 3.87]. Inner segment (IS) and outer segment (OS) thinning was less pronounced, with an average distance from the EZ-loss boundary to layer thickness normalization of 1.20° [0.91, 1.48] for the IS and 0.60° [0.49, 0.72] for the OS. An additive model of allele severity explained 52.7% of variability in the age of criterion EZ-loss . CONCLUSION: Patients with ABCA4 -associated retinopathy exhibited significant alterations of photoreceptors outside of EZ-loss . DL-based analysis of photoreceptor laminae may help monitor disease progression and estimate the severity of ABCA4 variants. TRIAL REGISTRATION: ClinicalTrials.gov identifier: NCT01736293. FUNDING: National Eye Institute Intramural Research Program and German Research Foundation grant PF950/1-1.

6 October 2020 in Journal of Ophthalmology
Verified
Journal Article
Open access
PDF file
JSJasmine Y. Serpen
Jasmine Y. Serpen
LPLev Prasov
Lev Prasov
WZWadih M. Zein
Wadih M. Zein
CCCatherine A. Cukras
Catherine A. Cukras
DCDenise Cunningham
Denise Cunningham
LHLaryssa Huryn
Laryssa Huryn
Background/Aims. Optic disc drusen (ODD) are calcified deposits of proteinaceous material in the optic disc, and their burden in ocular conditions is unknown. As ODD can be associated with visual field defects further compromising already degenerating visual function in patients with retinal degenerations, it is important to further our knowledge of ODD in inherited eye disease. The present study aims to evaluate prevalence, demographic features, and optic disc parameters of eyes with superficial ODD in inherited eye conditions. Materials and Methods. Electronic medical records of patients evaluated in the Ophthalmic Genetics clinic at the National Eye Institute (NEI) between 2008 and 2018 were searched for a superficial ODD diagnosis. Color fundus and autofluorescence images were reviewed to confirm ODD, supplemented with optical coherence tomography (OCT) in uncertain cases when available. Demographic information, examination, and genetic testing were reviewed. Disc areas and disc-to-macula distance to disc diameter ratios (DM : DD) were calculated. Results. Fifty six of 6207 patients had photographically confirmed ODD (0.9%). Drusen were predominantly bilateral (66%), with a female (62%) and Caucasian (73%) predilection. ODD prevalence in our cohort of patients with inherited retinal degenerations was 2.5%, and ODD were more prevalent in the rod-cone dystrophy subgroup at 2.95% (OR = 3.3 [2.1–5.3], ) compared to the ophthalmic genetics cohort. Usher patients were more likely to have ODD (10/132, 7.6%, OR = 9.0 [4.3–17.7], ) and had significantly smaller discs compared to the rest of our ODD cohort (disc area: , DM : DD: ). Discussion. While an association between ODD and retinitis pigmentosa has been reported, this study surveys a large cohort of patients with inherited eye conditions and finds the prevalence of superficial ODD is lower than that in the literature. Some subpopulations, such as rod-cone dystrophy and Usher syndrome, had a higher prevalence than the cohort as a whole.

1 October 2020 in Investigative Ophthalmology & Visual Science
Verified
Journal Article
Open access
PDF file
MVMalena Daich Varela
Malena Daich Varela
EUEhsan Ullah
Ehsan Ullah
SYSairah Yousaf
Sairah Yousaf
BBBrian P. Brooks
Brian P. Brooks
RHRobert B Hufnagel
Robert B Hufnagel
LHLaryssa Huryn
Laryssa Huryn
Purpose: Genetic variation in PDE6C is associated with achromatopsia and cone dystrophy, with only a few reports of cone–rod dystrophy in the literature. We describe two pediatric and two adult patients with PDE6C related cone and cone–rod dystrophy and the first longitudinal data of a pediatric patient with PDE6C-related cone dystrophy. Methods: This cohort of four patients underwent comprehensive ophthalmologic evaluation at the National Eye Institute's Ophthalmic Genetics clinic, including visual field testing, retinal imaging and electroretinogram (ERG). Next-generation sequencing–based genetic testing was performed and subsequent analysis of the variants was done through three-dimensional protein models generated by Phyre2 and Chimera. Results: All cases shared decreased best-corrected visual acuity and poor color discrimination. Three of the four patients had a cone–rod dystrophy, presenting with an ERG showing decreased amplitude on both photopic and scotopic waveforms and a mild to moderately constricted visual field. One of the children was diagnosed with cone dystrophy, having a preserved peripheral field. The children had none to minor structural retinal changes, whereas the adults had clear macular dystrophy. Conclusions: PDE6C-related cone–rod dystrophy consists of a severe phenotype characterized by early-onset nystagmus, decreased best-corrected visual acuity, poor color discrimination, progressive constriction of the visual field, and night blindness. Our work contributes with valuable information toward understanding the visual prognosis and allelic heterogeneity of PDE6C-related cone and cone–rod dystrophy.